Skip to main content

TWO SIGMA SECURITIES, LLC

Broker-Dealer

Position in NVAX — Novavax Inc

CIK 1450144 NEW YORK, NY

Position in NVAX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$97,242
-$13,779 QoQ
Shares Held
10,323
-24.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#162
of 263 holders
Holding Since
Jun 2021
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVAX Over Time

Shares Held

Position Value (USD)

Derivatives in NVAX

reported options exposure · as of Jun 30, 2022
CallValue
$2,905,795
CallShares
56,500
PutValue
$2,504,641
PutShares
48,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TWO SIGMA SECURITIES, LLC holds $22,449,685 across 103 Biotechnology names. NVAX ranks #40 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVAX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $97,242 10,323
2026-03-31 $111,021 13,639
2023-06-30 $84,605 11,387
2022-06-30 $2,905,795 56,500
2022-06-30 $534,100 10,385
2022-06-30 $2,504,641 48,700
2022-03-31 $1,356,853 18,423
2022-03-31 $3,483,645 47,300
2022-03-31 $5,700,510 77,400
2021-12-31 $260,816 1,823
2021-12-31 $257,526 1,800
2021-09-30 $3,669,387 17,700
2021-09-30 $1,534,094 7,400
2021-06-30 $467,082 2,200
2021-06-30 $1,231,398 5,800